|
|
Hauptstraße 6
Stockach, 78333 USA
phone:0180 5 18 80 18
fax:0180 5 17 70 17
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.apovia.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Vaccines for the prevention and treatment of infectious diseases. |
|
| Management |
| Martin Steiner, CEO of Apovia AG; George B Thornton, Managing Director |
| |
|
|
| |
|
| Keywords |
| vaccine infectious disease, malaria, influenza, otitis media, bacterial meningitis, InfectiousDisease |
|
|
|
| Description |
|
Apovia is focused on the prevention and treatment of infectious diseases through vaccines that are based on its VAXCORE carrier platform. |
|
| Products / Services |
Apovia's product candidates under development include vaccines against malaria, influenza, otitis media and bacterial meningitis.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members